Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alprazolam
amgen
applied genetics
autosomal recessive disorders
bioethics
biotech
biotechnology
boston blog main
cgrp inhibitors
chronic migraine
chronic pain syndromes
clinical trials
colucid pharmaceuticals
disorders of globin and globulin proteins
drug enforcement administration
eli lilly
emerging technologies
fda
gene delivery
health in africa
hematopathology
hereditary hemolytic anemias
indiana
indiana blog main
indiana top stories
lasmiditan
life extension
life sciences
medical genetics
medical research
migraine research foundation
molecular biology
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
triptans
What
causes
2
×
condition
2
×
new
2
×
acute
addresses
anemia
approval
blood
called
cell
create
crispr
decades
disease
doesn’t
drug
editing
eli
fda
figured
friday
gene
giant
giving
help
hope
lasmiditan
lilly
lilly’s
medication
migraine
mutation
oks
patients
pharmaceutical
possible
repair
researchers
scientists
second
Language
unset
Current search:
condition
×
new
×
causes
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@theverge.com
7 years ago
A new gene-editing technique could help treat sickle cell anemia